Women are too often NOT active agents in decisions to stop cancer directed treatments near the end of life. We CAN/MUST do better--shared decision making is KEY! https://t.co/9jnTsh0fD4 @dukeobgyn @DukeCancer
— Brittany Davidson (@Brittdavidsonmd) March 24, 2021
#OvarScore is here!! Download it today https://t.co/Jyy9XOY4ou #DESKTOPIII #SOC1 #secondarycytoreduction #ovariancancer @IJGCfellows @IGCSociety @ESGO_society @IJGConline pic.twitter.com/HIMkZZ0qIu
— Pedro T Ramirez (@pedroramirezMD) March 22, 2021
It was my pleasure sharing some thoughts on communication skills in oncology with the participants of @ecancer #Kolkata21 meeting today morning. The video is already available to watch for those interested: https://t.co/OU1Ix5npOL
— Bishal Gyawali (@oncology_bg) April 11, 2021
NEW online: SOC-1 trial—Secondary #cytoreduction followed by #chemotherapy versus chemotherapy alone in platinum-sensitive relapsed #ovariancancer #surgery #gyncsm https://t.co/cFq41Ck9EW pic.twitter.com/5gFsIGLBDA
— The Lancet Oncology (@TheLancetOncol) March 9, 2021